Amanote Research
Register
Sign In
HD Chemotherapy in the Treatment of Poor Prognostic or Advansed Stage Breast Cancer Patients
Bone Marrow Transplantation
- United Kingdom
doi 10.1038/sj.bmt.1702618
Full Text
Open PDF
Abstract
Available in
full text
Categories
Transplantation
Hematology
Date
September 1, 2000
Authors
Unknown
Publisher
Springer Nature
Related search
CD44v9 as a Poor Prognostic Factor of Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy
Breast Cancer
Nuclear Medicine
Radiology
Pharmacology
Oncology
Imaging
Medicine
Prognostic Factors for Triple-Negative Breast Cancer Patients Receiving Preoperative Systemic Chemotherapy
Clinical Breast Cancer
Cancer Research
Oncology
Long-Term Prognostic and Predictive Factors in 107 Stage II/III Breast Cancer Patients Treated With Anthracycline-Based Neoadjuvant Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
Prognostic and Predictive Factors in Early-Stage Breast Cancer
Oncologist
Cancer Research
Medicine
Oncology
Temporary Ovarian Suppression in the Prevention of Chemotherapy-Induced Premature Menopause in Early-Stage Breast Cancer Patients
European Oncology and Haematology
Oncology
Hematology
The Practicability of a Novel Prognostic Index (PI) Model and Comparison With Nottingham Prognostic Index (NPI) in Stage I–III Breast Cancer Patients Undergoing Surgical Treatment
PLoS ONE
Multidisciplinary
Successful Collection of Peripheral Blood Stem Cells Mobilized by High-Dose Etoposide for Patients With Chemotherapy-Resistant and/or Poor Prognostic Testicular Cancer
Japanese Journal of Urology
Urology
The Effect of Chemotherapy on Subjective Cognitive Function in Younger Early-Stage Breast Cancer Survivors Treated With Chemotherapy Compared to Older Patients
Breast Cancer Research and Treatment
Cancer Research
Oncology
Overexpression of CXXC5 Is a Strong Poor Prognostic Factor in ER+ Breast Cancer
Oncology Letters
Cancer Research
Oncology
